In vitro activity, safety and in vivo efficacy of the novel bumped kinase inhibitor BKI-1748 in non-pregnant and pregnant mice experimentally infected with Neospora caninum tachyzoites and Toxoplasma gondii oocysts

Bumped kinase inhibitors (BKIs) target the apicomplexan calcium-dependent protein kinase 1 (CDPK1). BKI-1748, a 5-aminopyrazole-4-carboxamide compound when added to fibroblast cells concomitantly to the time of infection, inhibited proliferation of apicomplexan parasites at EC(50)s of 165 nM (Neospo...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Parasitol Drugs Drug Resist
Main Authors: Imhof, Dennis, Anghel, Nicoleta, Winzer, Pablo, Balmer, Vreni, Ramseier, Jessica, Hänggeli, Kai, Choi, Ryan, Hulverson, Matthew A., Whitman, Grant R., Arnold, Samuel L.M., Ojo, Kayode K., Van Voorhis, Wesley C., Doggett, J. Stone, Ortega-Mora, Luis M., Hemphill, Andrew
פורמט: Artigo
שפה:Inglês
יצא לאור: Elsevier 2021
נושאים:
Regular article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC8144743/
https://ncbi.nlm.nih.gov/pubmed/34030110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2021.05.001
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים